Cryoport(CYRX)
HQ US65% share
manufactured · input
Liquid-nitrogen vapor-phase Dewar containers validated for 7–10 day -196°C transport of autologous CAR-T cell therapy; each patient infusion requires a unique round-trip N=1 shipment.
0
Source countries
1
Companies
1
Goods affected
0
Claims on record
What depends on it
1 essential American goods rely on car-t cryogenic dry shipper somewhere upstream in their supply chain.
Who makes it
1 company produce car-t cryogenic dry shipper.